MODERNA ($MRNA) posted quarterly earnings results on Friday, August 1st. The company reported earnings of -$2.13 per share, beating estimates of -$3.03 by $0.90. The company also reported revenue of $142,000,000, beating estimates of $115,200,472 by $26,799,528.
You can see Quiver Quantitative's $MRNA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
MODERNA Insider Trading Activity
MODERNA insiders have traded $MRNA stock on the open market 4 times in the past 6 months. Of those trades, 3 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MRNA stock by insiders over the last 6 months:
- STEPHANE BANCEL (Chief Executive Officer) has made 2 purchases buying 160,314 shares for an estimated $5,004,318 and 0 sales.
- PAUL SAGAN purchased 31,620 shares for an estimated $1,004,251
- ABBAS HUSSAIN sold 312 shares for an estimated $8,736
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MODERNA Hedge Fund Activity
We have seen 320 institutional investors add shares of MODERNA stock to their portfolio, and 365 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BAILLIE GIFFORD & CO removed 13,941,013 shares (-35.8%) from their portfolio in Q1 2025, for an estimated $395,227,718
- D. E. SHAW & CO., INC. added 3,867,436 shares (+218.7%) to their portfolio in Q1 2025, for an estimated $109,641,810
- TWO SIGMA INVESTMENTS, LP added 3,790,063 shares (+570.8%) to their portfolio in Q1 2025, for an estimated $107,448,286
- TWO SIGMA ADVISERS, LP added 3,704,800 shares (+3572.6%) to their portfolio in Q1 2025, for an estimated $105,031,080
- MORGAN STANLEY added 3,190,707 shares (+75.1%) to their portfolio in Q1 2025, for an estimated $90,456,543
- MANUFACTURERS LIFE INSURANCE COMPANY, THE removed 2,951,658 shares (-88.3%) from their portfolio in Q1 2025, for an estimated $83,679,504
- FMR LLC added 2,465,395 shares (+13.2%) to their portfolio in Q1 2025, for an estimated $69,893,948
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MODERNA Congressional Stock Trading
Members of Congress have traded $MRNA stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MRNA stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 02/25 and 1 sale worth up to $15,000 on 04/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
MODERNA Analyst Ratings
Wall Street analysts have issued reports on $MRNA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Underperform" rating on 07/22/2025
- JP Morgan issued a "Underweight" rating on 05/22/2025
- UBS issued a "Buy" rating on 05/02/2025
To track analyst ratings and price targets for MODERNA, check out Quiver Quantitative's $MRNA forecast page.
MODERNA Price Targets
Multiple analysts have issued price targets for $MRNA recently. We have seen 9 analysts offer price targets for $MRNA in the last 6 months, with a median target of $32.0.
Here are some recent targets:
- Dimple Gosai from B of A Securities set a target price of $25.0 on 07/22/2025
- Jessica Fye from JP Morgan set a target price of $26.0 on 05/22/2025
- Eliana Merle from UBS set a target price of $70.0 on 05/02/2025
- Gena Wang from Barclays set a target price of $40.0 on 05/02/2025
- Luca Issi from RBC Capital set a target price of $28.0 on 05/02/2025
- Cory Kasimov from Evercore ISI Group set a target price of $32.0 on 05/02/2025
- Matthew Harrison from Morgan Stanley set a target price of $32.0 on 04/09/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
